Cinclus Pharma Stock Price Today
Cinclus Pharma stock price today. Cinclus Pharma (ST:CINPHA) is currently trading at Skr12.00 SEK, up 2.56% today. Over the past 52 weeks, shares have ranged between Skr10.82 and Skr19.46. This page tracks Cinclus Pharma's live share price on the ST exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see Cinclus Pharma cash conversion from operations.
Share Price of Cinclus Pharma — Daily History & Trading Volume
Share price of Cinclus Pharma over the past year. The chart below tracks Cinclus Pharma's daily closing share price and trading volume on the ST exchange over the past year, giving a clear view of recent price momentum and liquidity.
Cinclus Pharma Stock Trading Volume
Cinclus Pharma stock trading volume shows how many shares changed hands each day on the ST exchange.
Cinclus Pharma Income Statement — Revenue, Profit & Earnings by Year
Cinclus Pharma's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Revenue | Skr57.47 Million | Skr4.58 Million | Skr5.96 Million | Skr10.57 Million |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Research & Development | Skr198.40 Million | Skr136.66 Million | Skr166.68 Million | Skr157.18 Million |
| SG&A | Skr57.25 Million | Skr36.85 Million | Skr39.56 Million | Skr64.11 Million |
| Total Operating Expenses | Skr255.65 Million | Skr173.51 Million | Skr206.24 Million | Skr221.30 Million |
| Operating Income | Skr-198.18 Million | Skr-168.93 Million | Skr-200.28 Million | Skr-210.73 Million |
| EBITDA | — | — | — | — |
| EBIT | — | — | — | — |
| Interest Expense | Skr395.00K | Skr8.73 Million | Skr7.45 Million | Skr76.00K |
| Income Before Tax | Skr-183.71 Million | Skr-167.28 Million | Skr-214.61 Million | Skr-231.01 Million |
| Income Tax Expense | — | — | — | — |
| Net Income | Skr-183.97 Million | Skr-168.03 Million | Skr-215.12 Million | Skr-249.07 Million |
Cinclus Pharma Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Cinclus Pharma's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total Assets | Skr546.56 Million | Skr601.01 Million | Skr94.41 Million | Skr185.77 Million |
| Total Current Assets | Skr536.85 Million | Skr600.47 Million | Skr94.09 Million | Skr184.88 Million |
| Cash & Equivalents | — | — | — | — |
| Short-term Investments | — | — | — | — |
| Net Receivables | Skr16.06 Million | Skr0.00 | — | — |
| Inventory | — | — | — | — |
| Property, Plant & Equipment | — | — | — | — |
| Goodwill | — | — | — | — |
| Total Liabilities | Skr177.16 Million | Skr45.68 Million | Skr171.21 Million | Skr58.90 Million |
| Total Current Liabilities | Skr136.79 Million | Skr45.49 Million | Skr164.42 Million | Skr46.10 Million |
| Long-term Debt | — | — | — | — |
| Net Debt | — | — | Skr42.37 Million | — |
| Total Stockholder Equity | Skr369.39 Million | Skr555.33 Million | Skr-76.80 Million | Skr126.87 Million |
| Retained Earnings | Skr-952.80 Million | Skr-772.00 Million | Skr-606.84 Million | Skr-394.16 Million |
Cinclus Pharma Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Cinclus Pharma generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Cash Flow | Skr-74.65 Million | Skr-178.37 Million | Skr-209.19 Million | Skr-192.08 Million |
| Capital Expenditures | Skr1.13 Million | Skr0.00 | Skr0.00 | Skr0.00 |
| Free Cash Flow | Skr-75.78 Million | Skr-178.37 Million | Skr-209.19 Million | Skr-192.08 Million |
| Investing Cash Flow | — | — | — | — |
| Financing Cash Flow | — | — | — | — |
| Dividends Paid | — | — | — | — |
| Stock-Based Compensation | Skr3.17 Million | Skr2.87 Million | Skr2.44 Million | — |
| Depreciation | Skr2.38 Million | Skr1.34 Million | Skr1.25 Million | Skr1.11 Million |
| Change in Cash | Skr-77.84 Million | Skr476.83 Million | Skr-86.29 Million | Skr34.07 Million |
Cinclus Pharma Earnings History — EPS Actual vs. Analyst Estimates
Track Cinclus Pharma's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jun 30, 2026 | -1.69 | — | — |
| Mar 31, 2026 | -1.91 | — | — |
| Dec 31, 2025 | -1.31 | — | — |
| Sep 30, 2025 | -0.87 | — | — |
| Jun 30, 2025 | -1.04 | — | — |
| May 20, 2025 | -0.72 | — | — |
| Feb 20, 2025 | -1.17 | — | — |
| Nov 14, 2024 | -0.79 | — | — |